What does this research mean for the field?

A novel Four-Axis Translation Framework enables the evaluation of extra-carpal pharmacological evidence for treating Kienböck disease and the wider carpal avascular necrosis family, identifying iloprost and teriparatide as plausible candidates despite the lack of direct lunate data. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.ESTABLISHES_NEW_DIRECTION.

What question did this study set out to answer?

To determine whether pharmacological evidence from extra-carpal osteonecrosis sites can be translated to treat Kienböck disease and the broader carpal avascular necrosis family.

September 3, 2026MedicinesOpen Access

Pharmacotherapy of Kienböck Disease and the Carpal Avascular Necrosis Family: A Narrative Review with a Four-Axis Translation Framework

View Full Paper

Ask AI

Bookmark

Authors

DTDimitar Tenev BHBenedikt Hochbein GEGeorgi Enev

Discussion

Member takes

Overview

Narrative review reveals potential drug targets for Kienböck disease using extra-carpal data, suggesting translation via a novel four-axis framework.

Key Points

To determine whether pharmacological evidence from extra-carpal osteonecrosis sites can be translated to treat Kienböck disease and the broader carpal avascular necrosis family.
Conducted a narrative review adhering to SANRA guidelines, searching PubMed, CrossRef, Google Scholar, and three specialty registries from inception to 2026.
Assessed eleven drug classes across eleven skeletal sites, with all references independently verified against primary sources.
Identified zero randomized or controlled pharmacotherapy trials specific to Kienböck disease, leaving all therapeutic rationale reliant on indirect extra-carpal evidence.
Identified iloprost as the drug candidate most consistently aligned across translation axes, while teriparatide provided the only randomized trial evidence demonstrating reversal of established osteonecrosis in medication-related osteonecrosis of the jaw.
Proposed a Four-Axis Translation Framework encompassing mechanistic alignment, anatomic concordance, Lichtman-stage applicability, and lunate-specific risk–benefit geometry.

Cite This Study

Tenev et al. (2026) studied this question.

synapsesocial.com/papers/6a9935d8636c6408cfa7e537 https://doi.org/10.3390/medicines13030027

View Full Paper

Ask AI

Bookmark

September 3, 2026MedicinesOpen Access

Pharmacotherapy of Kienböck Disease and the Carpal Avascular Necrosis Family: A Narrative Review with a Four-Axis Translation Framework

View Full Paper

Ask AI

Bookmark

Authors

DTDimitar Tenev BHBenedikt Hochbein GEGeorgi Enev

Discussion

Member takes

Overview

Narrative review reveals potential drug targets for Kienböck disease using extra-carpal data, suggesting translation via a novel four-axis framework.

Key Points

To determine whether pharmacological evidence from extra-carpal osteonecrosis sites can be translated to treat Kienböck disease and the broader carpal avascular necrosis family.
Conducted a narrative review adhering to SANRA guidelines, searching PubMed, CrossRef, Google Scholar, and three specialty registries from inception to 2026.
Assessed eleven drug classes across eleven skeletal sites, with all references independently verified against primary sources.
Identified zero randomized or controlled pharmacotherapy trials specific to Kienböck disease, leaving all therapeutic rationale reliant on indirect extra-carpal evidence.
Identified iloprost as the drug candidate most consistently aligned across translation axes, while teriparatide provided the only randomized trial evidence demonstrating reversal of established osteonecrosis in medication-related osteonecrosis of the jaw.
Proposed a Four-Axis Translation Framework encompassing mechanistic alignment, anatomic concordance, Lichtman-stage applicability, and lunate-specific risk–benefit geometry.

Cite This Study

Tenev et al. (2026) studied this question.

synapsesocial.com/papers/6a9935d8636c6408cfa7e537 https://doi.org/10.3390/medicines13030027

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark